Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1945 72
1946 233
1947 300
1948 330
1949 295
1950 503
1951 676
1952 752
1953 772
1954 898
1955 943
1956 892
1957 775
1958 691
1959 632
1960 703
1961 751
1962 820
1963 1082
1964 1576
1965 1228
1966 1062
1967 1220
1968 1380
1969 1771
1970 1868
1971 2620
1972 2967
1973 3261
1974 3327
1975 3250
1976 3109
1977 2885
1978 2998
1979 3161
1980 2738
1981 2511
1982 2731
1983 3131
1984 3329
1985 3456
1986 3301
1987 3900
1988 3629
1989 3874
1990 4030
1991 4168
1992 4310
1993 4443
1994 4370
1995 4425
1996 4432
1997 4635
1998 4626
1999 5082
2000 5152
2001 5554
2002 5657
2003 6112
2004 6329
2005 6665
2006 6731
2007 6996
2008 7184
2009 7389
2010 7904
2011 8759
2012 8689
2013 9273
2014 9767
2015 10344
2016 10699
2017 11316
2018 12433
2019 13233
2020 15248
2021 19360
2022 20179
2023 16465
2024 5829

Text availability

Article attribute

Article type

Publication date

Search Results

345,225 results

Results by year

Filters applied: . Clear all
Page 1
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
Thompson JA, Schneider BJ, Brahmer J, Achufusi A, Armand P, Berkenstock MK, Bhatia S, Budde LE, Chokshi S, Davies M, Elshoury A, Gesthalter Y, Hegde A, Jain M, Kaffenberger BH, Lechner MG, Li T, Marr A, McGettigan S, McPherson J, Medina T, Mohindra NA, Olszanski AJ, Oluwole O, Patel SP, Patil P, Reddy S, Ryder M, Santomasso B, Shofer S, Sosman JA, Wang Y, Zaha VG, Lyons M, Dwyer M, Hang L. Thompson JA, et al. J Natl Compr Canc Netw. 2022 Apr;20(4):387-405. doi: 10.6004/jnccn.2022.0020. J Natl Compr Canc Netw. 2022. PMID: 35390769 Review.
Cancer immunotherapies: advances and bottlenecks.
Rui R, Zhou L, He S. Rui R, et al. Front Immunol. 2023 Aug 24;14:1212476. doi: 10.3389/fimmu.2023.1212476. eCollection 2023. Front Immunol. 2023. PMID: 37691932 Free PMC article. Review.
Integrative Approaches to Cancer Immunotherapy.
Szeto GL, Finley SD. Szeto GL, et al. Trends Cancer. 2019 Jul;5(7):400-410. doi: 10.1016/j.trecan.2019.05.010. Trends Cancer. 2019. PMID: 31311655 Free PMC article. Review.
New Frontiers in the Treatment of Type 1 Diabetes.
Warshauer JT, Bluestone JA, Anderson MS. Warshauer JT, et al. Cell Metab. 2020 Jan 7;31(1):46-61. doi: 10.1016/j.cmet.2019.11.017. Epub 2019 Dec 12. Cell Metab. 2020. PMID: 31839487 Free PMC article. Review.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
Puzanov I, Diab A, Abdallah K, Bingham CO 3rd, Brogdon C, Dadu R, Hamad L, Kim S, Lacouture ME, LeBoeuf NR, Lenihan D, Onofrei C, Shannon V, Sharma R, Silk AW, Skondra D, Suarez-Almazor ME, Wang Y, Wiley K, Kaufman HL, Ernstoff MS; Society for Immunotherapy of Cancer Toxicity Management Working Group. Puzanov I, et al. J Immunother Cancer. 2017 Nov 21;5(1):95. doi: 10.1186/s40425-017-0300-z. J Immunother Cancer. 2017. PMID: 29162153 Free PMC article.
Immunotherapy: a promising approach for glioma treatment.
Yasinjan F, Xing Y, Geng H, Guo R, Yang L, Liu Z, Wang H. Yasinjan F, et al. Front Immunol. 2023 Sep 7;14:1255611. doi: 10.3389/fimmu.2023.1255611. eCollection 2023. Front Immunol. 2023. PMID: 37744349 Free PMC article. Review.
345,225 results
You have reached the last available page of results. Please see the User Guide for more information.